Elliot McKerr

Pharmaceutical company focused on cannabinoids and psilocybin products, HYTN Innovations Inc. (OTCPK:HYTNF), partnered with 4C LABS, an importer and distributor of cannabis-based pharmaceuticals in the United Kingdom. The British Columbia-based company said this collaboration will enable the...

HYTN Innovations Inc (CSE:HYTN), a leader in the development and manufacture of psychoactive and psychotropic compounds, including cannabis and psilocybin, has completed the acquisition of Prism Scientific Labs Inc, as announced in their July 19 press release. This strategic move is intended to...

HYTN Innovations Inc. (CSE:HYTN) has successfully initiated cultivation of psilocybin mushrooms under its Dealer’s License granted by Health Canada in accordance with the Controlled Drugs and Substances Act. The has installed equipment at its Kelowna facility, including high-performance...

HYTN Cannabis Inc., a wholly owned subsidiary of HYTN Innovations Inc. (CSE:HYTN), has been awarded a Controlled Drugs and Substances Dealer’s License by Health Canada allowing for the sale, possession, production, assembly and transportation of psilocybin, a naturally occurring psychedelic...

HYTN Cannabis Inc. wholly owned subsidiary of HYTN Innovations Inc., (CSE:HYTN) has developed and listed for sale its all-new Nano Gummies product. The Nano Gummies, complement the company’s current offering of all-natural, sugar and sweetener-free sparkling cannabis beverages. According to...

HYTN Cannabis Inc., wholly owned subsidiary of HYTN Innovations Inc. (CSE:HYTN) has been awarded a license by Health Canada allowing for the sale of cannabis for medical purposes. This follows a list of license achievements including a standard processing license, cannabis research license, an...

HYTN Innovations Inc. (CSE:HYTN) has successfully sold cannabis flower to serve the Australian medical cannabis market under the Promethean BioPharma brand pursuant to the company’s supply agreement with TCann Pty Ltd. “HYTN is focused on innovating at all levels within the cannabis...

HYTN Innovations Inc. (CSE:HYTN) announced that it has begun accepting orders directly from Provincial buyers. This news builds on HYTN's February 22 announcement that it had been awarded approval to sell cannabis products to provincially and territorially authorized retailers and that the...

HYTN Innovations Inc.’s (CSE:HYTN) subsidiary HYTN Cannabis Inc., has awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers. National sales of HYTN's...